Selecting the right formulation for your molecule

Formulation development underpinned by biopharmaceutics & clinical knowledge

Quotient Sciences has more than 30 years of experience developing a breadth of formulations across a range of indications.  With expertise in simple and complex dosage forms, we have formulated over 1,500 molecules. Our unique track record in clinical research, means we know what it takes to develop formulations across the full development pathway from preclinical to late stage.

From fit-for-purpose preclinical and first-in-human (FIH) dosage forms to optimized drug products for late stage development and market, we work with you to develop the most appropriate formulation based on the physicochemical and biopharmaceutics properties of your molecule.

Operating from our state-of-the-art facilities in the U.S. and U.K. and a with global team of over 200 formulation and analytical scientists, we offer you a comprehensive and tailored formulation development service. 

What Our Clients Say

"Quotient Sciences was the idal partner for early clinical development of our new drug class."

-Modag

Get in touch to find out how Quotient Sciences can put speed, precision and quality at the heart of your pipeline
Connect With Quotient

Hello, this piece of content has moved!

Arcinova has officially become Quotient Sciences. You will now be automatically redirected to Quotient Sciences’ website.
If you are not automatically redirected, please click here www.quotientsciences.com